Pharmaco Kinetic and Pharmacokinetic-Pharmacodynamic Variability of Infliximab.

Trial Profile

Pharmaco Kinetic and Pharmacokinetic-Pharmacodynamic Variability of Infliximab.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Dec 2013

At a glance

  • Drugs Infliximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacodynamics; Pharmacokinetics
  • Acronyms FAKIR
  • Most Recent Events

    • 23 Feb 2010 Actual end date (November 2009) added as reported by ClinicalTrials.gov.
    • 23 Feb 2010 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 30 Jan 2010 Actual number of patients (84) added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top